Literature DB >> 20587511

Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties.

T Tadmor1, A Aviv, A Polliack.   

Abstract

Merkel cell carcinoma (MCC) is a rare and aggressive skin tumor. The link between tumorigenesis and immunosuppression is well known and the increased prevalence of MCC in human immunodeficiency virus carriers and organ transplant recipients and in patients with hemato-oncological neoplasias is now well recognized over the past decade. In this respect, chronic lymphocytic leukemia (CLL) seems to be the most frequent neoplasia associated with the development of MCC. Very recently, a newly described virus, the Merkel cell polyomavirus, was found in ∼80% of MCC tumor samples and is in fact the first member of the polyomavirus family to be associated with human tumors. The virus appears to play a role in the pathogenesis of MCC and may constitute the missing link between immunosuppression and the development of MCC. This review summarizes the current knowledge relating to MCC and its pathogenesis, stressing the link with hematologic neoplasias in general and to CLL in particular. We describe the permissive immunologic environment, which enables the virus-containing tumor cells to survive and proliferate in disorders like CLL. More studies are still needed to confirm this appealing theory in a more convincing manner.

Entities:  

Mesh:

Year:  2010        PMID: 20587511     DOI: 10.1093/annonc/mdq308

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  26 in total

1.  Merkel cell carcinoma and chronic lymphocytic leukemia presenting as collision tumor: a possible pitfall in cutaneous lesions.

Authors:  Silvia Uccella; Francesca Magnoli; Fausto Sessa; Stefano La Rosa
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

2.  Prognostic significance of lymph node ratio in patients with Merkel cell carcinoma.

Authors:  Alexandra Fochtmann; Georg Haymerle; Rainer Kunstfeld; Johannes Pammer; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-07       Impact factor: 2.503

Review 3.  Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Authors:  Teresa Amaral; Ulrike Leiter; Claus Garbe
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

4.  Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumour.

Authors:  Tamar Tadmor; Irena Liphshitz; Ariel Aviv; Ola Landgren; Micha Barchana; Aaron Polliack
Journal:  Br J Haematol       Date:  2012-03-06       Impact factor: 6.998

Review 5.  Chronic lymphocytic leukaemia.

Authors:  Thomas J Kipps; Freda K Stevenson; Catherine J Wu; Carlo M Croce; Graham Packham; William G Wierda; Susan O'Brien; John Gribben; Kanti Rai
Journal:  Nat Rev Dis Primers       Date:  2017-01-19       Impact factor: 52.329

Review 6.  Merkel cell carcinoma: update and review.

Authors:  Timothy S Wang; Patrick J Byrne; Lisa K Jacobs; Janis M Taube
Journal:  Semin Cutan Med Surg       Date:  2011-03

7.  Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.

Authors:  Maryam M Asgari; Monica M Sokil; E Margaret Warton; Jayasri Iyer; Kelly G Paulson; Paul Nghiem
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

Review 8.  Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.

Authors:  Natalie Vandeven; Paul Nghiem
Journal:  Immunotherapy       Date:  2016-07       Impact factor: 4.196

9.  Merkel cell carcinoma of skin-current controversies and recommendations.

Authors:  Avi Assouline; Patricia Tai; Kurian Joseph; Ji Dong Lian; Claude Krzisch; Edward Yu
Journal:  Rare Tumors       Date:  2011-04-04

10.  Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada.

Authors:  Sonia Toracchio; Annette Foyle; Vojtech Sroller; Jon A Reed; Jun Wu; Claudia A Kozinetz; Janet S Butel
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.